Phase 2a, randomized, double ‐blind, placebo‐controlled, multicentre, parallel‐group study of an H4R‐antagonist (JNJ‐39758979) in adults with uncontrolled asthma

Clinical&Experimental Allergy, EarlyView.

Source: Clinical and Experimental Allergy - June 7, 2018 Category: Allergy & Immunology Authors: A. P. Kollmeier , A. Greenspan , X. L. Xu , P. E. Silkoff , E. S. Barnathan , M. J. Loza , J. Jiang , B. Zhou , B. Chen , R. L. Thurmond Source Type: research